Japan's medical devices market is expected to expand from approximately US$49.74 billion in 2025 to US$85.77 billion by 2035, with a compound annual growth rate of approximately 5.6%. Key growth factors include population aging and the rising prevalence of chronic diseases, the expansion of minimally invasive treatment and home healthcare, and the integration of digital technologies.
Japan's medical devices market is projected to expand from US$49.74 billion in 2025 to US$85.77 billion by 2035, supported by the country's advanced healthcare infrastructure and regulatory environment. Annual growth is expected to be 5.6%, with the adoption of home healthcare, growing demand for minimally invasive devices and integration with digital technologies serving as key pillars of growth.
Growth drivers include population aging and the rising prevalence of chronic diseases, with demand expected to increase in areas such as cardiovascular disease, diabetes and respiratory diseases. In addition, the spread of home healthcare and remote monitoring, the integration of digital technologies, and the development of devices with new functions enabled by advances in materials technology are expected to drive market growth.
Product segments span a wide range, including respiratory, cardiovascular, orthopedic, diagnostic imaging, endoscopy and ophthalmology. Demand is attracting particular attention for devices designed for home use and minimally invasive treatment devices. The development of new materials and high-precision devices is expected to promote market growth by addressing treatment needs.
In future competition, comprehensive value, including digital connectivity, implementation support, traceability and data utilization, will be increasingly important. Collaboration with overseas companies, strengthening domestic development capabilities and more efficient approval processes through regulatory improvements are expected to be key to competitiveness.